Pfizer brought in the most money by far off of the pandemic of any of the pharmaceutical companies, with a total of $56.74 billion in revenue from its BioNTech vaccine and antiviral treatment in 2022 alone, according to Reuters on Monday.
Advertisement
Moderna came in second to Pfizer with $18.4 billion in revenue last year from its vaccine.
Sales may fall by nearly two-thirds this year due to inventories being built up around the world and higher immunity rates, according to company and analyst estimates.
[Not to mention rising skepticism about new boosters and a lack of long-range testing of vaccines in general. It’s not been helped by government efforts to quash debate and demands for more data, either. — Ed]
Join the conversation as a VIP Member